TOP TIERMARKET NEWSWIRE
News & sentiment

ZEVRA THERAPEUTICS I (ZVRA) — News & AI sentiment

ZEVRA THERAPEUTICS I (ZVRA) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 54.2/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $1.1M — net selling of $1.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 54.2/100
Insider net (90d)
$1.1M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

ZVRA news in the last 24 hours, 7 days, 30 days and 90 days

How much ZVRA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowZVRA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days654.2/100ZVRA headlines →
Last 90 days3047.7/100ZVRA headlines →

Latest stories on ZVRA

Sep 2
Sep 2
Aug 25
Aug 21
Aug 21
Aug 21
Aug 7
Aug 6
Aug 6
Aug 6
Aug 5
Aug 5
Aug 5
Aug 4
Aug 3
Aug 3
Jul 28
BTIG cuts Zevra Therapeutics price target on EU setback
Investing.com Analyst Ratings34 · bearishanalyst
Jul 28
Jul 27
H.C. Wainwright reiterates Zevra stock rating on EU setback
Investing.com Analyst Ratings42 · neutralanalyst
Jul 27
Jul 24
Jul 24
Jul 24
Jul 24
Zevra plunges on EU snub for rare disease therapy
Seeking Alpha28 · bearishgeneral
Jul 24
Open ZVRA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →